Fernando Andreu
Algemeen Directeur bij 2cureX ApS
Actieve functies van Fernando Andreu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Algemeen Directeur | 01-01-2021 | - |
Loopbaan van Fernando Andreu
Eerdere bekende functies van Fernando Andreu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
2CUREX AB | Algemeen Directeur | 01-02-2021 | 29-12-2023 |
Sysmex Inostics GmbH
Sysmex Inostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sysmex Corp., Sysmex Inostics GmbH is a German company that develops advanced genetic testing technologies. The company is based in Hamburg, Germany. The CEOs are Bhuwnesh Agrawal, Seido Biwa, Mamoru Kubota. The company was founded by Luis Diaz. Sysmex Inostics was acquired by Sysmex Corp. from Indivumed GmbH on September 25, 2013. | Algemeen Directeur | - | - |
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Corporate Officer/Principal | - | - |
Indivumed, Inc. | Algemeen Directeur | - | - |
Opleiding van Fernando Andreu
ESADE Business School | Masters Business Admin |
Statistieken
Internationaal
Duitsland | 3 |
Denemarken | 3 |
Spanje | 2 |
Operationeel
Chief Executive Officer | 4 |
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Sectoraal
Health Technology | 3 |
Technology Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
2CUREX AB | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Sysmex Inostics GmbH
Sysmex Inostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Sysmex Corp., Sysmex Inostics GmbH is a German company that develops advanced genetic testing technologies. The company is based in Hamburg, Germany. The CEOs are Bhuwnesh Agrawal, Seido Biwa, Mamoru Kubota. The company was founded by Luis Diaz. Sysmex Inostics was acquired by Sysmex Corp. from Indivumed GmbH on September 25, 2013. | Commercial Services |
Indivumed, Inc. |
- Beurs
- Insiders
- Fernando Andreu
- Ervaring